Inflammatory fibroid polyps remain a subject of significant diagnostic and pathogenetic interest within gastrointestinal pathology. While historically classified as reactive or inflammatory pseudotumors driven by local physical, chemical, or infectious stimuli, modern molecular pathology has fundamentally shifted this perspective [1]. The discovery of activating mutations within the gene encoding the platelet-derived growth factor receptor alpha (PDGFRA) in a substantial proportion of IFPs has firmly established their status as true neoplastic mesenchymal proliferations rather than purely reactive processes [1,5].

Demographically, IFPs demonstrate a broad age distribution but exhibit a notable peak incidence between the fifth and seventh decades of life [1]. The presentation of an IFP in an elderly patient carries heightened clinical risk. Geriatric patients possess reduced physiological reserve and an elevated baseline susceptibility to rapid clinical deterioration, including bowel ischemia, transmural necrosis, and secondary peritonitis, if an acute mechanical occlusion is not promptly diagnosed and surgically managed [1,4].

Small bowel IFPs possess a distinct propensity for precipitating acute abdominal crises. As documented across multiple clinical series and case reports, polyps arising within the jejunum or ileum rarely present with insidious dyspeptic symptoms or chronic anemia; instead, due to the narrower caliber of the small bowel compared to the stomach, they rapidly manifest with subocclusive syndromes or acute mechanical obstruction driven by intussusception [2-4,6]. Unlike gastric IFPs, which are frequently amenable to diagnostic and therapeutic endoscopic mucosal resection or snare polypectomy during routine esophagogastroduodenoscopy, small bowel lesions remain occult until complications arise [1]. Consequently, cross-sectional imaging via contrast-enhanced CT is indispensable, serving as the gold standard modality for identifying the pathognomonic target sign, localizing the mechanical lead point, and staging associated bowel wall distress [1,4].

Histopathologically, the diagnosis relies on recognizing the classic triad of a submucosal stromal proliferation of spindle cells, a prominent network of blood vessels with concentric perivascular cuffing, and a heavy infiltration of eosinophils [4,6]. Although the vast majority of IFPs remain strictly confined within the submucosal layer, rare cases exhibiting deep tissue invasion extending into the muscularis propria or subserosal layers have been reported in contemporary literature, challenging the traditional dogma of purely localized disease and further supporting their neoplastic nature [5]. Furthermore, atypical immunohistochemical profiles—such as occasional focal loss or negativity for CD34, which is typically a reliable diagnostic adjunct—can complicate pathological interpretation, necessitating meticulous correlation with morphological features [5].

Ultimately, because small bowel IFPs can clinically and radiologically mimic malignant mesenchymal neoplasms such as Gastrointestinal Stromal Tumors (GISTs) or adenocarcinomas, definitive surgical resection remains both the primary therapeutic intervention for acute obstruction and the definitive diagnostic modality.